| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |